A new treatment for metastatic melanoma could hold the promise of extending the life of people suffering from skin cancer. 560 315 TelegraphPlayer_9142145 tag ?> 12:01AM GMT 14 Mar 2012 A trial in 132 people with metastatic melanoma, found that on average they lived for almost 16 months when put on the drug, called vemurafenib. By comparison, those with skin cancer that has already spread to other organs who are put on standard treatments tend to live for between six and 10 months after diagnosis, according to the researchers, writing in the New England Journal of Medicine (NEJM). However, it only works in those with a mutation of the BRAF gene called V600, present in about half of?
Health from
WN.com ? Health News
for more reading
http://www.health.netsimpler.com/pill-offers-hope-to-skin-cancer-suffers/
Source: http://www.health.netsimpler.com/pill-offers-hope-to-skin-cancer-suffers/
snow day neti pot iron chef bath and body works coupons jeff probst jeff probst king jong il dead
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.